Accuracy of the AI-Based Smart Scope® Test as a Point-of-Care Screening and Triage Tool Compared to Colposcopy: A Pilot Study.
Source check: Source checked. Not independent scientific confirmation.
Finding: In a prospective pilot of 130 women, Smart Scope® AI-assisted visual inspection with acetic acid (VIA) was compared with colposcopy at the same visit; positive findings triggered biopsy. Smart Scope AI accuracy was 76.53% against colposcopy (n=130). Histopathology was available for only 18 participants; against that reference, reported Smart Scope AI accuracy was 83.33%, sensitivity 83.33% and specificity 83.33%. The small histology subset leaves wide uncertainty and does not establish screening benefit in routine practice.
Technology: Cloud-based Smart Scope® AI analyzes digital cervical images for lesions during visual inspection with acetic acid.
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- Cloud-based AI assessed digital cervical images during VIA and returned lesion screening results; the study compared them with colposcopy and, in a subset, histopathology.
- Test and result
- All 130 participants received colposcopy and Smart Scope AI-assisted VIA during the same visit. Against colposcopy, AI accuracy was 76.53%; among 18 with histopathology, reported AI accuracy, sensitivity and specificity were each 83.33%.
- Limitation / still unknown
- Only 18 participants had histopathology, so the gold-standard comparison is imprecise. This single pilot does not establish external reproducibility or improved screening outcomes.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12022722/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 4/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.